Enovis (NYSE: ENOV) net income
Enovis reported a net loss of $1,184m for fiscal 2025; in fiscal 2024 it reported a net loss of $825.5m. Earnings per share were −$20.75.
Enovis's best year of the last 10 was fiscal 2017. The biggest drop was in fiscal 2018, −7.2%. It reported a loss in 5 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$1,184m | — | −52.7% | −$20.75 |
| 2024 | −$825.5m | — | −39.2% | −$14.93 |
| 2023 | −$33.3m | — | −1.9% | −$0.61 |
| 2022 | −$13.3m | −118.5% | −0.9% | −$0.25 |
| 2021 | $71.7m | +68.1% | 5.0% | $0.47 |
| 2020 | $42.6m | — | 3.8% | $0.31 |
| 2019 | −$527.6m | −476.4% | −15.9% | −$3.89 |
| 2018 | $140.2m | −7.2% | 6.4% | $1.16 |
| 2017 | $151.1m | +17.9% | 7.8% | $1.23 |
| 2016 | $128.1m | — | 4.0% | $1.04 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Enovis net income compared with its sector
By net income for its latest fiscal year, Enovis ranks 496th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Enovis, −52.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 494th | Revolution Medicines | −$1,131m | — |
| 495th | Quidelortho | −$1,132m | −41.5% |
| 496th | Enovis | −$1,184m | −52.7% |
| 497th | Insmed | −$1,277m | −210.5% |
| 498th | Perrigo | −$1,425m | −33.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Enovis
- How much did Enovis earn in fiscal 2025?
- Enovis reported a net loss of $1,184m for fiscal 2025. In fiscal 2024 it reported a net loss of $825.5m.
- What are the earnings per share of Enovis?
- They were −$20.75 in fiscal 2025, compared with −$14.93 in fiscal 2024.
- What was the most profitable year for Enovis?
- Of its last 10 fiscal years, fiscal 2017, with $151.1m.
- Where does Enovis rank in its sector by net income?
- It ranks 496th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Enovis come from?
- From the annual report (Form 10-K) that Enovis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Enovis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Enovis: the Enovis page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.